Pillar Biosciences is committed to enabling affordable precision medicine. We are focused on developing novel genomic and proteomic technologies for cancer diagnosis and treatment.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/12/16 | $18,000,000 |
ORI Healthcare Fund | undisclosed | |
| 05/27/25 | $34,500,000 | Strategic |
Illumina, Inc Soleus Capital | undisclosed |
